Sulphadimidine Acetylation Test for Classification of Patients as Slow or Rapid Inactivators of Isoniazid

Rao, K. V. N.; Mitchison, D. A.; Nair, N. G. K.; Prema, K.; Tripathy, S. P.
August 1970
British Medical Journal;8/29/1970, Vol. 3 Issue 5721, p495
Academic Journal
No abstract available.


Related Articles

  • Lesson of the Week. Thomas, R.H. Meyrick; Payne, C.M.E. Rowland; Black, M.M. // British Medical Journal (Clinical Research Edition);7/25/1981, Vol. 283 Issue 6286, p287 

    Focuses on the development of pellagra in patients treated with isoniazid in India. Conversion of tryptophan to nicotinic acid; Rate of metabolism of isoniazid; Prevalence of slow acetylator.

  • Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism. Sistanizad, Mohammad; Azizi, Ebrahim; Khalili, Hosein; Hajiabdolbaghi, Mahboobeh; Gholami, Kheirollah; Mahjub, Reza // Iranian Journal of Pharmaceutical Research;Sep2011, Vol. 10 Issue 3, p633 

    The aim of this study was to determine the association of n-acetyltransferase-2 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Iranian pulmonary tuberculosis patients. Acetylating phenotypes was studied in 50 Iranian pulmonary tuberculosis patients using metabolic ratio of...

  • Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype. Harland, S.J.; Facchini, V.; Timbrell, J.A. // British Medical Journal;7/26/1980, Vol. 281 Issue 6235, p273 

    Human populations show a bimodal distribution for the rate of acetylation of certain drugs.[1] The lupus erythematosus-like syndrome associated with hydrallazine is almost exclusively confined to slow acetylators,[2] there being only two cases reported of this syndrome occurring in the rapid...

  • Influence of acetylator phenotype on antidepressant effects of phenelzine. Paykel, E. S.; West, P. S.; Rowan, P. R.; Parker, A. R.; Parker, R R // British Journal of Psychiatry;Sep82, Vol. 141, p243 

    Acetylator phenotype, determined by blood levels after sulphadimidine, was related to outcome in a controlled trial of phenelzine in patients with depression and mixed anxiety depression. Slow acetylators showed more improvement and greater phenelzine-placebo differences than did fast...

  • Fenotyp oksydacji i fenotyp acetylacji w chorobie Alzheimera -- doniesienie wstÄ™pne. Milejski, Piotr; Orzechowska-Juzwenko, Krystyna; Niewiński, Przemysław; Hurkacz, Magdalena; Czarnik-Matusewicz, Henryk; Leszek, Jerzy; Rudzik, Jacek; Grotthus, Bartosz // Psychiatria Polska;2007, Vol. 41 Issue 2, p261 

    Aim. The relationship between genetically determined polymorphic oxidation and acetylation and susceptibility to some disease has aroused much interest. The aim of our study was to evaluate whether patients with Alzheimer's disease differ from healthy persons in their ability to oxidize...

  • Chronic Isoniazid Poisoning. Rubin, David H.; Carbone, John; Fong, Ben; Borowitz, Drucy; Leven, Robert; Grossman, Moses // Clinical Pediatrics;Jul1983, Vol. 22 Issue 7, p518 

    The article focuses on chronic isoniazid poisoning. Isoniazid (INH) is recommended currently for the treatment of recent tuberculin converters. With the influx of many refugees into the United States, the number of tuberculin reactors and active cases of tuberculosis has risen and, as a result,...

  • Isoniazid and its Hydrazine Metabolite in Patients with Tuberculosis. Pea, F.; Milaneschi, R.; Baraldo, M.; Talmassons, G.; Furlanut, M. // Clinical Drug Investigation;1999, Vol. 17 Issue 2, p145 

    Objective: The serum profiles of isoniazid and its hydrazine metabolite were investigated in patients with tuberculosis in steady-state conditions in the hope of identifying a pharmacokinetic approach that could be useful in the clinical assessment of other patientswith the same disease state....

  • Is there any difference between acetylator phenotypes in tuberculosis patients and healthy subjects? Khalili, Hossein; Dashti-Khavidaki, Simin; Amini, Mohsen; Mahjub, Reza; Hajiabdolbaghi, Mahboobeh // European Journal of Clinical Pharmacology;Mar2010, Vol. 66 Issue 3, p261 

    Many studies have been done to determine the distribution of acetylator phenotypes among populations of different geographic origin. The goal of this study was to investigate the acetylator phenotypes of the Iranian population and compare them between tubercular patients and healthy subjects....

  • Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population. Salazar-González, R.; Gómez, R.; Romano-Moreno, S.; Medellín-Garibay, S.; Núñez-Ruíz, A.; Magaña-Aquino, M.; Milán-Segovia, R.; Portales-Pérez, D. // Molecular Biology Reports;Dec2014, Vol. 41 Issue 12, p7833 

    Arylamine N-acetyltransferase 2 (NAT2) metabolizes isoniazid (INH) and Single Nucleotide Polymorphisms (SNP) responsible for its activity has been reported. The aim of this study in the Mexican mestizo population was to evaluate NAT2 expression at the protein level in immune cells, as well as...

  • Diabetic dimorphism according to acetylator status. Burrows, A.W.; Hockaday, T.D.R.; Mann, J.I.; Taylor, J.G. // British Medical Journal;1/28/1978, Vol. 1 Issue 6107, p208 

    Classifies diabetic dimorphism according to acetylator status. Susceptibility of diabetics to neuropathy; Rate of acetylation of sulphadimidine; Prevalence of fast acetylators.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics